Nanosized forms of drugs (A Review)

Pharmaceutical Chemistry Journal

Volumn 43, Issue 3, 2009, Pages 163-170

  Nazarov, G V ^a   Galan, S E ^a   Nazarova, E V ^a   Karkishchenko, N N ^a   Muradov, M M ^a   Stepanov, V A ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Drugs; Nanosized forms; Targeted delivery of drugs

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CISPLATIN; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; LIPOSOME; LURTOTECAN; NANOCAPSULE; NANOCRYSTAL; NANOSPHERE; NYSTATIN; PACLITAXEL; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD BRAIN BARRIER; BREAST CANCER; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; GLIOBLASTOMA; HUMAN; KAPOSI SARCOMA; KIDNEY CARCINOMA; MICROENCAPSULATION; MYCOSIS; NANOBIOTECHNOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; SKIN LYMPHOMA;

EID: 67651172773     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-009-0259-2     Document Type: Article

References (62)

1. Yu M Evdokimov 2006 Ross. Nanotekhnol. 1 1 256 264
2. JH Thrall 2004 Radiology 230 315 318
3. K Bogunia-Kubik M Sugisaka 2002 Biosystems 65 123 138
4. SE McNeil 2005 J. Leukocyte Biol. 78 585 594
5. JC Olivier 2005 NeuroRx: J. Am. Soc. Exp. NeuroTherapeutics 2 108 119
6. AA Vertegel RW Siegel JS Dordick 2004 Langmuir 20 6800 6807
7. VI Teichberg 2007 Proc. Natl. Acad. Sci. USA 104 18 7315 7316
8. JK Vasir MK Reddy VD Labhasetwar 2005 Curr. Nanosci. 1 47 64
9. SM Moghimi AC Hunter JC Murray 2001 Pharm. Rev. 53 2 283 318
10. P Borm FC Klaessig TD Landry 2006 Toxicol. Sci. 90 1 23 32
11. O Kayser A Lemke N Hernandez-Trejo 2005 Curr. Pharm. Biotechnol. 6 3 5
12. RF Schinazi R Sijbesma G Srdanov 1993 Antimicrob. Agents Chemother. 37 1707 1710
13. K Kostarelos 2006 Nanomedicine 1 1 1 3
14. S Gelperina K Kisich MD Iseman 2005 Am. J. Respir. Crit. Care Med. 172 12 1487 1490
15. KA Witt PD Thomas 2006 Am. Assoc. Pharm. Sci. J. 8 1 76 88
16. SS Davis L Illum 1998 Int. J. Pharm. 176 1 8
17. A Asthana AS Chauhan PV Diwan 2005 AAPS PharmSciTech 6 3 536 542
18. P Couvreur G Barratt E Fattal 2002 Crit. Rev. Ther. Drug Carrier Syst. 19 99 134
19. E Oberdorster 2004 Environ. Health Perspect. 112 1058 1062
20. K Krauel T Pitaksuteepong NM Davies 2004 Am. J. Drug Deliv. 4 2 251 259
21. LH Reddy RSR Murthy 2004 Biomed. Pap. 148 2 161 166
22. SM Moghimi AC Hunter JC Murray 2005 FASEB J. 19 3 311 330
23. ES Severin AV Rodina 2006 Usp. Biol. Khim. 46 43 64
24. AE Gulyaev SE Gelperina IN Skidan 1999 Pharm. Res. 16 1564 1569
25. J Kreuter P Ramge V Petrov 2003 Pharm. Res. 20 409 416
26. F Moussa P Chreiten P Dubois 1995 Fullerene Sci. Technol. 3 333 342
27. N Charbi M Pressac M Hadchouel 2005 Nano Lett. 5 2578 2585
28. WA Scrivens JM Tour KE Creek 1994 J. Am. Chem. Soc. 116 4517 4518
29. RG Alargova S Deguchi K Tsujii 2001 J. Am. Chem. Soc. 123 10460 10467
30. S Deguchi RG Alargova K Tsujii 2001 Langmuir 17 6013 6017
31. ID Fortner DY Lyon CM Sayes 2005 Environ. Sci. Technol. 39 4307 4316
32. G. V. Andrievsky, M. V. Kosevich, O. M. Vovk, et al., J. Chem. Sco. Chem. Commun., No. 12, 1281 - 1282 (1995).
33. J Labille J Brant F Villieras 2006 Fullerenes, Nanotubes Carbon Nanostruct. 14 307 314
34. E Oberdorster S Zhu TM Blickley 2006 Carbon 44 1112 1120
35. L. B. Piotrovskii and O. I. Kiselev, Fullerenes in Biology [in Russian], OOO Izd. ROSTOK, St. Petersburg (2006).
36. T Mashino K Shimotohno N Ikegami 2005 Bioorg. Med. Chem. Lett. 15 1107 1109
37. T Mashino D Nishikawa K Takahashi 2003 Bioorg. Med. Chem. Lett. 13 4395 4397
38. GL Marcorin T Da Ros S Castellano 2000 Org. Lett. 2 25 3955 3958
39. S Bosi L Feruglio T Da Ros 2004 J. Med. Chem. 47 27 6711 6715
40. DA Tomalia H Baker J Dewald 1985 Polym. J. 17 1 117 132
41. GR Newkome VK Gupta GR Baker 1985 J. Org. Chem. 50 2003 2005
42. AM Muzafarov EA Rebrov VS Papkov 1991 Usp. Khim. 60 7 1596 1612
43. S Lebreton S Monaghan M Bradley 2001 Aldrichimica Acta 34 3 75 83
44. D Bhadra S Bhadra S Jain 2003 Int. J. Pharm. 257 111 124
45. WA Freeman WL Mock NY Shih 1981 J. Am. Chem. Soc. 103 7367 7368
46. AE Beezer ASH King IK Martin 2003 Tetrahedron 59 3873 3880
47. A. K. Patri, I. J. Majoros, and J. R. Bake, Curr. Opin. Chem. Biol., No. 6, 466 - 471 (2002).
48. W Meier 2000 Chem. Soc. Rev. 29 295 303
49. I Roy TY Ohulchanskyy HE Pudavar 2003 J. Am. Chem. Soc. 125 7860 7865
50. J. E. Vandegaer, ed., Microencapsulation, Process and Application, Plenum Press, New York, London (1974).
51. V. D. Solodovnik, Microencapsulation [in Russian], Khimiya, Moscow (1980).
52. R. Alshady, ed., Microspheres, Microcapsules and Liposomes, MML-series, Vol. 1, 2, Citus Books, London (1999).
53. M. S. Vilesova, N. I. Aizenshtadt, M. S. Bosenko, et al., Zh. Ross. Khim. Ob'va im. D. I. Mendeleeva, No. 5 - 6, 1 - 10 (2001).
54. E. Merisko-Liversidge, in: Particles, J. Marty, ed., Marcel Dekker, Orlando (2002).
55. K Uekama 2004 Chem. Pharm. Bull. 52 8 900 915
56. AV Astakhov NB Demin 2004 Khim.-farm. Zh 38 2 46 49
57. R. H. Muller, J. M. Schwitzer, and F. N. Bushrab, in: Nanoparticle Technology for Drug Delivery, R. P. Gupta, ed., Taylor & Francis Group, New York (2006), pp. 21 - 52.
58. F. Troester, Controlled Release Society 31st Annual Meeting, Honolulu (2004).
59. EV Tolcheva NA Oborotova 2006 Ross. Bioter. Zh. 5 54 61
60. AP Kaplun LB Shon Yu M Krasnopol'skii 1999 Vopr. Med. Khim. 54 3 12
61. D. D. Lasic, Liposomes: From Physics to Applications, Elsevier, Amsterdam (1993).
62. L. I. Barsukov, Soros. Obraz. Zh., No. 10, 2 - 9 (1998).